‘Eris’ Variant Increases as New COVID-19 Hospitalizations Decline

New COVID-19 hospital admissions have declined for the second consecutive week

In a promising development, new COVID-19 hospital admissions have declined for the second consecutive week, according to data from the Centers for Disease Control and Prevention. However, amidst this positive trend, the EG.5 variant, also known as ‘Eris,’ is spreading and is responsible for nearly 30% of new infections. While the World Health Organization considers the global public health risk posed by EG.5 to be “low,” experts are warning of the possibility of fall and winter waves of the virus. This article examines the recent decline in COVID-19 hospitalizations and the emerging threat of the Eris variant.

For the first time in more than two months, weekly coronavirus hospitalizations in the United States have decreased. This decline in hospital admissions is an encouraging sign that the efforts to control the spread of COVID-19, including vaccination campaigns and public health measures, are having a positive impact. However, experts remain cautious, emphasizing the need for continued vigilance and adherence to preventive measures.

While the decline in hospitalizations is a positive development, the rise of the EG.5 variant, known as ‘Eris,’ is a cause for concern. Eris has become the most prevalent variant globally, accounting for nearly 30% of new infections. Although the World Health Organization assesses the global public health risk posed by Eris as “low,” it is important to closely monitor its spread and impact on the effectiveness of existing vaccines.

As experts warn of potential fall and winter waves of the virus, it is crucial for individuals to get updated COVID-19 vaccines. Vaccination remains one of the most effective tools in combating the spread of the virus and reducing the severity of illness. Staying informed about the latest vaccine recommendations and following public health guidelines can help protect individuals and communities from the ongoing threat of COVID-19, including emerging variants like Eris.